首页|Turning point of organoid transplantation:first-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa

Turning point of organoid transplantation:first-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa

扫码查看
原文链接
  • 万方数据
  • 维普

Chang-Jun Zhang、Zi-Bing Jin

展开 >

Beijing Institute of Ophthalmology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730 China

National Science Fund for Distinguished Young Scholars

82125007

2024

10.1007/s11427-023-2531-3

中国科学:生命科学(英文版)
中国科学院

中国科学:生命科学(英文版)

CSTPCD
影响因子：0.806
ISSN：1674-7305
年,卷(期)：2024.67(5)